LNX2
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
ligand of numb-protein X 2 | MIM:609733 | Ensembl:ENSG00000139517 | HGNC:HGNC:20421 | PA134899015 | 13q12.2 |
GO terms in LNX2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0030165 | PDZ domain binding |
MF | IEA | GO:0046872 | metal ion binding |
BP | IEA | GO:0051260 | protein homooligomerization |
Gene expression in normal tissue: LNX2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in LNX2
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD562 | Navitoclax | 1 |
iGMDRD887 | Compound 23 citrate | 6 |
iGMDRD871 | BRD6368 | 1 |
iGMDRD286 | Nsc 632839 | 5 |
iGMDRD100 | Zebularine | 5 |
iGMDRD414 | MST-312 | 3 |
iGMDRD23 | Gossypol | 2 |
iGMDRD60 | Quinoclamine | 1 |
iGMDRD300 | Tozasertib | 3 |
iGMDRD52 | Rotenone | 3 |
iGMDRD267 | Oligomycin A | 2 |
iGMDRD705 | Nakiterpiosin | 6 |
iGMDRD221 | Tamoxifen | 1 |
iGMDRD219 | Bax channel blocker | 1 |
iGMDRD499 | PDMP | 1 |
iGMDRD375 | GW-405833 | 5 |
iGMDRD634 | SCHEMBL2608041 | 2 |
iGMDRD280 | CYTOCHALASIN B | 6 |
iGMDRD889 | Compound 7d-cis | 2 |
iGMDRD512 | nutlin 3 | 6 |
iGMDRD554 | CHEMBL1434137 | 3 |
iGMDRD484 | Pluripotin | 6 |
iGMDRD79 | Gemcitabine | 2 |
iGMDRD483 | SCH-529074 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in LNX2